Literature DB >> 10531348

Role of human Cds1 (Chk2) kinase in DNA damage checkpoint and its regulation by p53.

K Tominaga1, H Morisaki, Y Kaneko, A Fujimoto, T Tanaka, M Ohtsubo, M Hirai, H Okayama, K Ikeda, M Nakanishi.   

Abstract

In response to DNA damage, mammalian cells adopt checkpoint regulation, by phosphorylation and stabilization of p53, to delay cell cycle progression. However, most cancer cells that lack functional p53 retain an unknown checkpoint mechanism(s) by which cells are arrested at the G(2)/M phase. Here we demonstrate that a human homolog of Cds1/Rad53 kinase (hCds1) is rapidly phosphorylated and activated in response to DNA damage not only in normal cells but in cancer cells lacking functional p53. A survey of various cancer cell lines revealed that the expression level of hCds1 mRNA is inversely related to the presence of functional p53. In addition, transfection of normal human fibroblasts with SV40 T antigen or human papilloma viruses E6 or E7 causes a marked induction of hCds1 mRNA, and the introduction of functional p53 into SV40 T antigen- and E6-, but not E7-, transfected cells decreases the hCds1 level, suggesting that p53 negatively regulates the expression of hCds1. In cells without functional ataxia telangiectasia mutated (ATM) protein, phosphorylation and activation of hCds1 were observed in response to DNA damage induced by UV but not by ionizing irradiation. These results suggest that hCds1 is activated through an ATM-dependent as well as -independent pathway and that it may complement the function of p53 in DNA damage checkpoints in mammalian cells.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10531348     DOI: 10.1074/jbc.274.44.31463

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  28 in total

1.  p53 down-regulates CHK1 through p21 and the retinoblastoma protein.

Authors:  V Gottifredi; O Karni-Schmidt; S S Shieh; C Prives
Journal:  Mol Cell Biol       Date:  2001-02       Impact factor: 4.272

Review 2.  Dial 9-1-1 for p53: mechanisms of p53 activation by cellular stress.

Authors:  M Ljungman
Journal:  Neoplasia       Date:  2000 May-Jun       Impact factor: 5.715

3.  Radiation-induced phosphorylation of Chk1 at S345 is associated with p53-dependent cell cycle arrest pathways.

Authors:  Hui Tian; Alexander T Faje; Siu Lan Lee; Timothy J Jorgensen
Journal:  Neoplasia       Date:  2002 Mar-Apr       Impact factor: 5.715

4.  Irofulven induces replication-dependent CHK2 activation related to p53 status.

Authors:  Yutian Wang; Timothy Wiltshire; Jamie Senft; Eddie Reed; Weixin Wang
Journal:  Biochem Pharmacol       Date:  2006-10-27       Impact factor: 5.858

5.  Ultraviolet irradiation-induced K(+) channel activity involving p53 activation in corneal epithelial cells.

Authors:  Ling Wang; Wei Dai; Luo Lu
Journal:  Oncogene       Date:  2005-04-21       Impact factor: 9.867

Review 6.  Stress-induced corneal epithelial apoptosis mediated by K+ channel activation.

Authors:  Luo Lu
Journal:  Prog Retin Eye Res       Date:  2006-09-07       Impact factor: 21.198

7.  Critical role of Caenorhabditis elegans homologs of Cds1 (Chk2)-related kinases in meiotic recombination.

Authors:  I Oishi; K Iwai; Y Kagohashi; H Fujimoto; K Kariya; T Kataoka; H Sawa; H Okano; H Otani; H Yamamura; Y Minami
Journal:  Mol Cell Biol       Date:  2001-02       Impact factor: 4.272

8.  Grp/DChk1 is required for G2-M checkpoint activation in Drosophila S2 cells, whereas Dmnk/DChk2 is dispensable.

Authors:  Hilda I de Vries; Lyle Uyetake; Willy Lemstra; Jeanette F Brunsting; Tin Tin Su; Harm H Kampinga; Ody C M Sibon
Journal:  J Cell Sci       Date:  2005-05-01       Impact factor: 5.285

9.  Phosphorylation of serine 18 regulates distinct p53 functions in mice.

Authors:  Hayla K Sluss; Heather Armata; Judy Gallant; Stephen N Jones
Journal:  Mol Cell Biol       Date:  2004-02       Impact factor: 4.272

10.  Emerging role of LRRK2 in human neural progenitor cell cycle progression, survival and differentiation.

Authors:  Javorina Milosevic; Sigrid C Schwarz; Vera Ogunlade; Anne K Meyer; Alexander Storch; Johannes Schwarz
Journal:  Mol Neurodegener       Date:  2009-06-15       Impact factor: 14.195

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.